
- Teacher: Christian Mosoni
- Teacher: Marco Ruella
This advanced MOOC explores the scientific discoveries and translational research projects that have driven the evolution of next-generation CAR-T cell therapies. Using twelve representative case studies, learners will examine how fundamental discoveries in immunology, cancer biology, metabolism, epigenetics, gene editing, and bioengineering have been translated into innovative cellular immunotherapies. The course emphasizes scientific reasoning, experimental design, and the translational pathway from laboratory discovery to clinical application.
The course is organized into 12 modules, each consisting of a 10-minute video lecture, downloadable slides, and a formative quiz designed to reinforce the concepts presented.
Module 1 - Gut Microbiome and CAR-T Therapy
Module 2 - Modulating BCL-2 to Enhance CAR-T Therapy
Module 3 - Microbiota Modulation and Antigen Cross-Presentation
Module 4 - Improving CAR-T Manufacturing and Quality Control
Module 5 - The BTLA-HVEM Axis in CAR-T Dysfunction
Module 6 - CD5 Deletion to Enhance Adoptive T-Cell Therapy
Module 7 - Epigenetic Modulation to Improve CAR-T Therapy
Module 8 - Harnessing the CD2 Axis in CAR-T Cells
Module 9 - CAR-T Cells Targeting IGHV4-34
Module 10 - Metabolic Reprogramming with β-Hydroxybutyrate
Module 11 - Engineering a Novel CD19 CAR: AT-101
Module 12 - Immune-Related Adverse Events after CAR-T Therapy
Each module includes:
-
one video lecture (~10 minutes)
-
downloadable slides
-
a formative quiz (3–5 questions)
Upon successful completion of this MOOC, the learner will be able to:
-
Interpret the experimental rationale underlying translational studies in cellular immunotherapy.
-
Analyze the molecular and cellular mechanisms regulating CAR-T cell activation, persistence, dysfunction, and therapeutic efficacy.
-
Evaluate innovative engineering strategies aimed at improving CAR-T cell function, including gene editing, checkpoint modulation, metabolic reprogramming, and epigenetic interventions.
-
Compare different approaches for enhancing manufacturing processes, product quality, and clinical performance of cellular therapies.
-
Interpret preclinical experimental data supporting the development of next-generation CAR-T cell therapies.
-
Critically evaluate how mechanistic discoveries are translated into novel therapeutic strategies.
-
Integrate concepts from immunology, cancer biology, metabolism, microbiology, and bioengineering to explain current advances in cellular immunotherapy.
-
Discuss emerging research directions that are likely to shape future generations of adoptive cellular therapies.
Quiz assessment.
Learners are expected to possess undergraduate-level knowledge of:
-
immunology
-
molecular biology
-
cell biology
Completion of the introductory MOOC "Foundations of Adoptive T-Cell Immunotherapy" is strongly recommended before enrolling in this course.
Marco Ruella
marco.ruella@unito.it
For technical issues:
edvancedeh@unito.it